Cancer News

St. Baldrick’s awards eight faculty with cancer research grantsJul 27, 2017
The St. Baldrick’s Foundation has announced its 2017 summer grant recipients, including eight from Baylor College of Medicine.
How CD44s gives brain cancer survival advantageJul 18, 2017
In the case of glioblastoma multiforme, researchers have discovered that the molecule CD44s seems to give cancer cells a survival advantage.
Baylor named site for NCI proteogenomics analysis, researchJun 27, 2017
The Lester and Sue Smith Breast Center was named the only Proteogenomic Translational Research Center site in the South.
Genomic sequencing may benefit parents of cancer patientsJun 26, 2017
Researchers report that genomic sequencing information may be more valuable for families of pediatric cancer patients than has previously been recognized.
Newly revealed cellular pathway may lead to cancer therapiesJun 15, 2017
Scientists have discovered a new cellular pathway that can promote and support the growth of cancer cells.
Analyses of liver cancer reveals unexpected genetic playersJun 15, 2017
Researchers analyzed 363 liver cancer cases to learn more about the genetic causes of this cancer, and to identify potential new therapeutic targets.
Cancer study assesses targets for personalized medicineMay 18, 2017
A study confirmed previously known cancer molecular changes and discovered others that had not been typically linked to cancer before.
Early detection highlighted for melanoma awareness month Apr 27, 2017
With longer days and more outdoor activities, Dr. Ida Orengo, professor of dermatology, addresses the dangers hiding behind sunburns and sun exposure, including melanoma.
Cancer mutation signatures focus of next McNair Symposium Apr 26, 2017
Cancers caused by mutations in cells that are then passed on during cell division will be the focus of this year’s Sixth Annual McNair Symposium.
Clinical trial results show benefit of brain cancer therapyApr 20, 2017
Researchers are investigating a new treatment option using modified T cells with anti-tumor properties with the goal of improving outcomes for patients with glioblastoma.